ARTIGO ORIGINAL 211Diagnosis and treatment of hyperfiltering blebsDiagnóstico e tratamento <strong>de</strong> bolsas fistulantes hiperfuncionantesSebastião Cronemberger 1 , Daniela Silveira <strong>de</strong> Faria 2 , Jamile Moreira Reimann 3 , Heloisa Andra<strong>de</strong>Maestrini 4 , Nassim Calixto 1ABSTRACTPurpose: To report on a new treatment for hyperfiltering bleb as well as its diagnostic criteria. Methods: Twenty eyes withhypotony due to hyperfiltering bleb caused by trabeculectomy with mitomicin C were treated with bleb resection. The diagnosisof hyperfiltering bleb followed these criteria: intraocular pressure lower than six mmHg (Goldmann tonometer); no inflammationin the anterior segment; presence of an elevated and/or diffuse and avascular bleb with or without microcysts; negative Sei<strong>de</strong>l test;no ciliochoroidal <strong>de</strong>tachment found with ultrasound biomicroscopy. We registered the following data pre and post operatively:type of glaucoma, visual acuity, bleb aspect and fundoscopic findings. A successful resolution of hypotony was achieved whenintraocular pressure ranged from six to 14 mmHg with or without antiglaucomatous medication. Results: At a minimum followupof 19 months ocular hypotony had been reversed in all eyes. At the last exam, intraocular pressure varied from eight to 14mmHg in 18 (90%) eyes; 12 (66.7%) eyes had no medication and six (33.3%) used antiglaucomatous medication. In two (10%)eyes, another trabeculectomy was necessary to control intraocular pressure. Hypotonic maculopathy <strong>de</strong>veloped preoperativelyin seven eyes and was reversed after bleb resection. Visual acuity improved in 15 (75%) eyes but did not change in five (25%).Conclusion: Bleb resection is a safe and a<strong>de</strong>quate treatment for ocular hypotony due to hyperfiltering bleb. It also restores visionin a consi<strong>de</strong>rable number of patients. The diagnosis of hyperfiltering bleb must follow rigorous criteria.Keywords: Trabeculectomy/adverse effects; Mitomycin/therapeutic use; Ocular hypotension; Treatment outcome.1Full Professor, Faculda<strong>de</strong> <strong>de</strong> Medicina da Universida<strong>de</strong> Fe<strong>de</strong>ral <strong>de</strong> Minas Gerais – UFMG – Belo Horizonte (MG), Brazil;2MD, Glaucoma service, Hospital São Geraldo – Hospital das Clínicas, Universida<strong>de</strong> Fe<strong>de</strong>ral <strong>de</strong> Minas Gerais – UFMG – BeloHorizonte (MG), Brazil;3Especialista em <strong>Oftalmologia</strong> pelo Hospital São Geraldo - Hospital das Clínicas da Universida<strong>de</strong> Fe<strong>de</strong>ral <strong>de</strong> Minas Gerais – UFMG– Belo Horizonte (MG), Brazil;4PhD, Faculda<strong>de</strong> <strong>de</strong> Medicina, Universida<strong>de</strong> Fe<strong>de</strong>ral <strong>de</strong> Minas Gerais – UFMG – Belo Horizonte (MG), Brazil;Study carried out at Department of Ophthalmology, Glaucoma Service, Hospital São Geraldo, Hospital das Clínicas, Universida<strong>de</strong>Fe<strong>de</strong>ral <strong>de</strong> Minas Gerais – UFMG – Belo Horizonte (MG), Brasil;The authors have no commercial interest in the products and equipment used in this studyRecebido para publicação em: 24/9/2010 - Aceito para publicação em 27/4/2011Rev Bras Oftalmol. 2011; 70 (4): 211-17
212Cronemberger S, Faria DS, Reimann JM, Maestrini HA, Calixto NRESUMOObjetivo: Relatar os resultados <strong>de</strong> uma nova técnica para o tratamento <strong>de</strong> bolsa hiperfuncionante, assim como seuscritérios diagnósticos. Métodos: Vinte olhos (20 pacientes) com hipotonia ocular causada por bolsa hiperfuncionante apóstrabeculectomia com mitomicina C foram tratados com ressecção da bolsa. O diagnóstico <strong>de</strong> bolsa hiperfuncionante obe<strong>de</strong>ceuaos seguintes critérios: pressão intraocular inferior a seis mmHg (tonometria <strong>de</strong> Goldmann); ausência <strong>de</strong> inflamação dosegmento anterior ocular; presença <strong>de</strong> bolsa fistulante elevada e/ou difusa e avascular com ou sem microcistos; teste <strong>de</strong> Sei<strong>de</strong>lnegativo; ausência <strong>de</strong> <strong>de</strong>scolamento ciliocoroidiano ao exame <strong>de</strong> UBM. Foram registrados no pré e pós-operatório: o tipo <strong>de</strong>glaucoma, a acuida<strong>de</strong> visual, o aspecto da bolsa e os achados oftalmoscópicos. A resolução da hipotonia foi alcançada quandoa pressão intraocular variou <strong>de</strong> seis a 14 mmHg sem ou sob medicação tópica antiglaucomatosa. Resultados: No seguimentomínimo <strong>de</strong> 19 meses, a hipotonia ocular foi revertida nos 20 olhos. No último exame, a pressão intraocular variou <strong>de</strong> oito a 14mmHg em 18 (90%) olhos; 12 (66,7%) olhos sem medicação e seis (33,3%) olhos sob medicação tópica. Em dois (20%) olhosfoi necessário nova trabeculetomia para controle da pressão intraocular. Maculopatia hipotônica foi diagnosticada no préoperatórioem sete olhos e foi revertida em todos eles após a ressecção da bolsa. A acuida<strong>de</strong> visual melhorou em 15 (75%)olhos e não se alterou em cinco (25%). Conclusão: A ressecção da bolsa é eficaz no tratamento da hipotonia ocular consequentea sua hiperfunção. Esse procedimento também recupera a visão num consi<strong>de</strong>rável número <strong>de</strong> pacientes. O diagnóstico <strong>de</strong>bolsa hiperfuncionante <strong>de</strong>ve obe<strong>de</strong>cer a critérios rigorosos.Descritores: Trabeculectomia/efeitos adversos; Mitomicina/uso terapêutico; Hipotensão ocular; Resultado <strong>de</strong> tratamentoINTRODUCTIONTrabeculectomy has proved effective in reducingintraocular pressure (IOP) and <strong>de</strong>laying theprogression of glaucoma (1-4) . This surgery canbring benefits such as improvement in quality of liferesulting from the reduction or total discontinuation ofmedications. It may even lead to lower and safer IOPlevels, particularly for patients in an advanced stage ofglaucoma (1) . In cases of refractory glaucoma,antimetabolites are used to improve trabeculectomyresults. However, antimetabolites can causecomplications such as postoperative ocular hypotony,which may be associated with shallow or a flat anteriorchamber, ciliochoroidal effusion, cataract andmaculopathy (5) .To date, the correct diagnosis and i<strong>de</strong>al treatmentof hyperfiltering bleb have not been conclusivelyestablished.Intrableb autologous blood injection (6-9) , freeconjunctival autografts (10) , free conjunctival patch (11) ,fascia lata (12) , Nd:YAG laser (13,14) , compression suture (15) ,and wi<strong>de</strong>-diameter contact lenses (16-18) have all been usedto treat ocular hypotony with varied <strong>de</strong>grees ofeffectiveness, thereby proving a lack of consensus on thissubject.The surgical approach to hyperfiltering bleb datesback to the 1960s (19-22) . In 2004 we published a fivecasepilot study of ocular hyptony (23) in which criteria forthe correct diagnosis of hyperfiltering bleb and itstreatment were established.The purposes of this study are: 1) to report resultsof treatment in a series of patients with ocular hypotonycaused by hyperfiltering bleb who un<strong>de</strong>rwent blebresection; 2) to substantiate criteria (23) for the correctdiagnosis of hyperfiltering bleb.METHODSTwenty eyes (20 patients) with ocular hypotonyafter trabeculectomy with mitomycin C (MMC) werediagnosed with hyperfiltering bleb (HB) after beingexamined by the same doctor (SC). Five eyes in this paperwere inclu<strong>de</strong>d in a smaller pilot study previouslypublished. (23) This study was performed according to thetenets of the Declaration of Helsinki and approved bythe ethics committee of the Fe<strong>de</strong>ral University of MinasGerais. All patients were informed of the purposes of thestudy and gave informed consent. The diagnosis of HBwas ma<strong>de</strong> with the following criteria: IOP lower than sixmmHg; (23) no inflammation in the anterior segment;elevated and/or diffuse and avascular bleb with or withoutmicrocysts (Figure 1A); negative Sei<strong>de</strong>l test (absence ofaqueous humour leakage in the Sei<strong>de</strong>l test, even afterslight compression of the ocular globe); no ciliochoroidal<strong>de</strong>tachment (CCD) found on the ultrasoundbiomicroscopy (UBM) carried out in the superior, inferior,nasal and temporal quadrants. Once criteria had beenfulfilled, we attempted to normalize the IOP with 1%atropine (one drop every 12 hours) and 0.1%<strong>de</strong>xamethasone (one drop every six hours) for at least30 days (24) . As clinical treatment failed to reverse ocularhypotony, all patients were submitted to HB resection bythe same surgeon (SC).Rev Bras Oftalmol. 2011; 70 (4): 211-17
- Page 1 and 2: vol. 70 - nº 4 - Julho / Agosto 20
- Page 3 and 4: 204Revista Brasileira de Oftalmolog
- Page 5 and 6: 206235 New technique to demonstrate
- Page 7 and 8: 208 Ambrósio Júnior RGerard Mouro
- Page 9: 210Ambrósio Júnior RDiferentes pl
- Page 13 and 14: 214Cronemberger S, Faria DS, Reiman
- Page 15 and 16: 216Cronemberger S, Faria DS, Reiman
- Page 17 and 18: 218ARTIGO ORIGINALUso profilático
- Page 19 and 20: 220Oliveira PRP, Simão LF, Simão
- Page 21 and 22: 222Oliveira PRP, Simão LF, Simão
- Page 23 and 24: 224ARTIGO ORIGINALPercepção da ad
- Page 25 and 26: 226Portes AJF, Silva MGO, Viana M,
- Page 27 and 28: 228Portes AJF, Silva MGO, Viana M,
- Page 29 and 30: 230ARTIGO ORIGINALExpectativas e co
- Page 31 and 32: 232Kara-Junior N, Mourad PCA , Esp
- Page 33 and 34: 234Kara-Junior N, Mourad PCA , Esp
- Page 35 and 36: 236 Marques FF, Marques DMV, Osher
- Page 37 and 38: 238ARTIGO ORIGINALPerfil da demanda
- Page 39 and 40: 240Pereira FB, Frasson M, D’Almei
- Page 41 and 42: 242Pereira FB, Frasson M, D’Almei
- Page 43 and 44: 244 Corso DD, Bonamigo EL, Corso MA
- Page 45 and 46: 246Corso DD, Bonamigo EL, Corso MA,
- Page 47 and 48: 248RELATO DE CASOPupila dilatada fi
- Page 49 and 50: 250Batista JLA, Grisolia ABD, Pazos
- Page 51 and 52: 252RELATO DE CASOPolypoidal choroid
- Page 53 and 54: 254Amaro MH, Roller AB, Motta CTPS,
- Page 55 and 56: 256Amaro MH, Roller AB, Motta CTPS,
- Page 57 and 58: 258Biancardi AL, Ambrosio Júnior R
- Page 59 and 60: 260Biancardi AL, Ambrosio Júnior R
- Page 61 and 62:
262Amaro MH, Amaro FAH, Roller AB,
- Page 63 and 64:
264Amaro MH, Amaro FAH, Roller AB,
- Page 65 and 66:
266Amaro MH, Amaro FAH, Roller AB,
- Page 67 and 68:
268Instruções aos autoresA Revist
- Page 69:
270RevistaBrasileira deOftalmologia